Stock comparison
Travere Therapeutics
TVTX$4.13BHealthcare Market cap, Sector
United Therapeutics
UTHR$24.13BHealthcare Market cap, Sector
Overall winner
United Therapeutics
TVTX 16 UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
TVTX1wins
6winsUTHR
32F
B71
75B
B76
54D
B76
75B
C62
2F
D46
42F
C64
37F
C64
Side-by-side metrics
| Metric | TVTX | UTHR |
|---|---|---|
| Market cap | $4.13B | $24.13B Winner |
| P/E (TTM) | Winner: - | 19.2x |
| EV/EBIT | Winner: - | 15.2x |
| ROIC (TTM) | -13.09% | 18.81% Winner |
| Gross margin | Winner: 93.95% | 86.58% |
| Net margin | -4.0% | 40.61% Winner |
| Revenue CAGR 5y | Winner: 38.9% | 17.22% |
| EPS CAGR 5y | - | 29.84% |
| Debt / Equity | 3.3x | - Winner |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
TVTX leads on
- EV/EBIT-vs 15.2x+123%
- P/E (TTM)-vs 19.2x+110%
- Revenue CAGR 5y38.9%vs 17.22%+56%
- Gross margin93.95%vs 86.58%+8%
UTHR leads on
- ROIC (TTM)18.81%vs -13.09%+170%
- Net margin40.61%vs -4.0%+110%
- Debt / Equity-vs 3.3x+100%
- Market cap$24.13Bvs $4.13B+83%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.